Acara Partners will be joining Sciton in NYC this September for two full days of clinical demos, advanced treatment techniques and emerging industry trends. Thought leaders and critically acclaimed dermatologists, plastic surgeons and industry partners will be in attendance for a weekend jam packed with demos of the hottest technologies, presentations of best practices of Continue Reading…
Allergan Announces FDA Approval of JUVÉDERM® VOLUX™ XC
Last week, Allergan made an exciting announcement that the FDA has approved JUVÉDERM® VOLUX™ XC! This FDA approval is major news for the aesthetic medical industry because JUVÉDERM VOLUX XC is the first and only hyaluronic acid (HA) filler for improving jawline definition to be approved by the FDA. Acara Partners is excited to learn Continue Reading…
Acara’s Consultants Contribute to MedEsthetics’ January/February Issue
Nina Balan, senior business consultant, and Angela Taylor, vice president of Practice Development & Consulting at Acara Partners, have contributed to MedEsthetics in a new article titled, “Make Retail Sales a Vital Part of Your Business.” Look out for the January/February 2022 issue in your mailbox this week. For those that are not yet subscribed Continue Reading…
What’s Hot & New in the MedSpa Industry?
As a leader in the aesthetic medical industry, Acara Partners needs to constantly monitor the state of our industry to stay up to date on what’s new, efficacious and on-trend in the marketplace with medical aesthetics technology. We’ve put together a short list of some of the hottest new technologies in the medspa world: BAREit™, Continue Reading…
An Early Holiday Season
Each holiday season brings opportunities to see and be seen — in photographs and at in-person and virtual parties alike. Imminent holiday get-togethers generate a demand to look your very best! An early holiday season is upon us. Already!? Supply chain strains, logistics delays and manufacturing crises, as well as an unfulfilled demand for labor Continue Reading…
Sunscreen Update, Understanding the FDA Monograph and More
The latest in Acara Partners’ guest blog series, this post comes from Ted Ebel, Chief Business Officer at Colorescience®. ––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– As we head into the summer months, it is an ideal time to review what is happening with the FDA sunscreen regulations. Not surprisingly, many people do not know that sunscreens are regulated as over-the-counter Continue Reading…
Essential Tips for an Initial Client Consultation
Francis Acunzo, CEO at Acara Partners, describes the essential tips needed to succeed with initial client consultations at your medical aesthetic practice: You have marketed and communicated the expertise and unique selling points of your medial aesthetic practice, and now a potential client is visiting for their initial consultation. What are the most important business Continue Reading…
Medical Aesthetic Trends for 2017
With 2017 upon us, just what does the medical aesthetic industry have in store for the upcoming year? Here is a list of the Top 5 potential trends in medical aesthetics for 2017: 1. Expansion of Kybella Usage 2016 beauty experts have called this nonsurgical procedure “the next Botox”. Kybella is an injection that contains Continue Reading…
Do Your Homework When Choosing Your Medical Spa
As demand for medical spa services continues to grow into 2016, it may become more difficult for the prospective patient to decide exactly where to bring his or her business. Due to this increasing popularity, it is becoming rare to live in an area where there is only one medical spa to choose from. A Continue Reading…
An Optimistic Outlook for the Medical Aesthetics Market
Recent findings from Research and Markets indicate positive projections for growth in the medical aesthetic industry through the year 2020. According to a recent press release, “the market is expected to reach $12.58 billion by 2020, at a compound annual growth rate of 10.8% from 2015 to 2020.” Factors that are driving this growth include Continue Reading…
